Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-20

Study Completion Date

2023-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fluid therapy is important in patients with sepsis and septic shock. There are many invasive and non-invasive methods to assess fluid responsiveness in patients. The specificities and sensitivities of these methods are highly variable. The reason for our study was to determine end-tidal co2 and fluid responsiveness in septic shock patients. The aim of the study was to evaluate the fluid response using the End-tidal CO2 difference in septic shock patients receiving intubated mechanical ventilation support.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock

NCT06572995

Sepsis Septic Shock Hemodynamic Instability +1 more

RECRUITING

CO2 Gap Changes in Septic Shock in Relation to Cardiac Output

NCT05578534

Septic Shock

COMPLETED

The Value of Peripheral Arterial Resistive Index in Evaluation of Tissue Perfusion in Patients With Septic Shock

NCT05902273

Shock, Septic

COMPLETED

Fluid Overload Quantification in Septic Shock

NCT04114162

Intensive Care Units Shock, Septic

COMPLETED

Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock

NCT05358912

Septic Shock Septicemia Intraabdominal Hypertension +1 more

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

End-tidal CO2 is a parameter that can be easily measured with our non-invasively available monitors. If results are positive, fluid response of patients can be measured with a non-invasive, easy-to-apply method.

The significance of end-tidal CO2 will be confirmed by the passive leg raise test. Assessment of fluid responsiveness with the passive leg raise test is currently seen as the non-invasive reference test used.

It has proven its accuracy and reliability in many studies. In the passive leg raise test, end-tidal CO2 will be compared between the group with and without fluid responsiveness.

Scope of the study: Patients hospitalized in the general and reanimation intensive care units of our hospital and diagnosed with septic shock for any reason.

Method(s) to be applied: All patients diagnosed with septic shock will be included in the study.

The passive leg raise test, will be applied to the patients, and cardiac output and end-tidal CO2 changes will be recorded with transthoracic echocardiography before and after.

Fluid responsiveness is considered to be present in patients whose stroke volume variation output change measured by echocardiography increases by 10% or more after the passive leg raise test.

Patients will be divided into 2 groups according to fluid responsiveness. Group-1 group with fluid responsiveness in passive leg raise test, Group-2 group with no fluid response in passive leg raise test. End-tidal CO2 will be compared between groups.

Passive leg raise test: After the patients are in a semi-sitting position (at least 2 minutes), two healthcare professionals will take the supine position and then lift their legs 45 degrees, wait for 2 minutes and return to the initial position.

With this maneuver, it is anticipated that approximately 150-300 ml of autotransfusion will be administered to the patient.

Statistical analyzes will be made with the SPSS 21 program. Normally distributed data will be expressed as mean ± standard deviation, non-normally distributed data will be expressed as median. Categorical data will be expressed as a percentage. The difference between the mean and median values will be evaluated according to the distribution of the data by Student's t or Mann-Whitney U test. Categorical data will be evaluated with the chi-square test. A p value \<0.05 will be considered significant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Septic Shock Hypovolemia Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group-1

group with fluid responsiveness in passive leg raise test After the patients are in a semi-sitting position (at least 2 minutes), two healthcare professionals will take the supine position and then lift their legs 45 degrees, wait for 2 minutes and return to the initial position.

10% change in stroke volume will be considered positive and patients will be divided into 2 groups as fluid-responsive and non-responsive.

End-tifdal co2, systolic, diastolic blood pressure, ppv values and vci distensibility

Intervention Type DEVICE

(0,1,3,5 minutes measurements will be taken) measured before and after the test will be recorded and compared.

Cardiac output and stroke volume variation, vci distensibility will be measured and recorded by a specialist cardiologist using siemens ocuson cv70 (Siemens AG Medical Solutions, Henkestrasse, the Germany) echocardiography before and after the test.

Group-2

group with no fluid response in passive leg raise test After the patients are in a semi-sitting position (at least 2 minutes), two healthcare professionals will take the supine position and then lift their legs 45 degrees, wait for 2 minutes and return to the initial position.

10% change in stroke volume will be considered positive and patients will be divided into 2 groups as fluid-responsive and non-responsive.

End-tifdal co2, systolic, diastolic blood pressure, ppv values and vci distensibility

Intervention Type DEVICE

(0,1,3,5 minutes measurements will be taken) measured before and after the test will be recorded and compared.

Cardiac output and stroke volume variation, vci distensibility will be measured and recorded by a specialist cardiologist using siemens ocuson cv70 (Siemens AG Medical Solutions, Henkestrasse, the Germany) echocardiography before and after the test.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

End-tifdal co2, systolic, diastolic blood pressure, ppv values and vci distensibility

(0,1,3,5 minutes measurements will be taken) measured before and after the test will be recorded and compared.

Cardiac output and stroke volume variation, vci distensibility will be measured and recorded by a specialist cardiologist using siemens ocuson cv70 (Siemens AG Medical Solutions, Henkestrasse, the Germany) echocardiography before and after the test.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* over 18 years old
* in circulatory shock
* Hemodynamically stable for 10 minutes (whether or not he takes vasoactive drugs)
* Followed in mechanical ventilation with invasive arterial monitoring

Exclusion Criteria

* pregnant
* Heart cannot be visualized by echocardiography
* Patients for whom passive leg raise test cannot be performed
* Bilateral lower extremity amputation
* Patients who are hemodynamically unstable

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

hüseyin özkarakaş

intensive care specialist Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR